1,128 results on '"Palmer D."'
Search Results
2. THE INTERPLANETARY NETWORK
3. THE INTERPLANETARY NETWORK
4. Beyond the Symptoms: Personalizing Giant Cell Arteritis Care through multidimensional patient reported outcome measure
5. Tech employers need to build their own talent to beat skills crisis
6. The economic impact of landslides affecting the Scottish road network
7. AB0703 TOWARDS TREAT-TO-TARGET PATIENT CENTRED CARE: DEVELOPMENT OF MULTIDIMENSIONAL DISEASE SPECIFIC PATIENT REPORTED OUTCOME MEASURES QUESTIONNAIRE FOR GIANT CELL ARTERITIS
8. POS0720 MEASURING FUNCTIONAL DISABILITY IN GIANT CELL ARTERITIS: THE VALIDITY, RELIABILITY AND RESPONSIVENESS OF THE GCA-DISABILITY INDEX (GCA-DI)
9. POS0699 GIANT CELL ARTERITIS CLINICAL DISEASE ACTIVITY MEASURES: RECOMMENDATIONS FOR USE IN CLINICAL PRACTICE
10. AB0324 DEVELOPMENT OF A MOBILE APP TO SUPPORT SELF-MANAGEMENT IN INDIVIDUALS WITH INFLAMMATORY ARTHRITIS
11. POS0464 DISEASE-AGNOSTIC SELF-MANAGEMENT PROGRAM: IMPACT ON DISEASE ACTIVITY AND HEALTH RELATED QUALITY OF LIFE MEASURES FOR PATIENTS LIVING WITH CHRONIC INFLAMMATORY ARTHRITIS
12. POS0465 ONLINE SELF-MANAGEMENT PROGRAM: A STEP FORWARD TOWARDS DIGITAL PLATFORM FOR PATIENT-TARGETED E-HEALTH
13. POS0734 ANALYSIS OF IMPROVEMENT IN GIANT CELL ARTERITIS: DEFINING THRESHOLDS FOR GCA-RESPONSE
14. POS1083 DIFFICULT TO TREAT INFLAMMATORY ARTHRITIS: MAKING THE DEFINITION MORE PRECISE AND TIME FRAMED
15. The 100-month Swift catalogue of supergiant fast X–ray transients
16. Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer
17. Stratified comparisons of Gemcitabine plus Capecitabine against Gemcitabine alone; further results from the ESPAC-4 trial
18. 54MO Quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+FOLFOX) in the randomised phase III, multi-centre, open-label ABC-06 trial
19. Modelling and prediction of PV module energy yield
20. Contributors
21. P-88 Clinical role of tumour markers in advanced biliary cancers (ABC) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+mFOLFOX) in the randomised phase III, multi-centre, open-label ABC-06 trial
22. P-85 Pre-surgical staging and surveillance after curative treatment for pancreatic ductal adenocarcinoma (PDAC): Survey of practice in the United Kingdom (UK)
23. SO-13 Pembrolizumab in patients with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the open-label, phase 2 KEYNOTE-224 study
24. The economic impact of landslides affecting the Scottish road network
25. POPULATION RISK FACTORS FOR SIGNIFICANT ANKLE LIGAMENT INJURY: LARGE MULTICENTRE UK BASED STUDY (SALI STUDY)
26. ASSOCIATION BETWEEN PAIN, FUNCTION, AND PHYSICAL ACTIVITY LEVELS AFTER SIGNIFICANT ANKLE LIGAMENT INJURY (SALI STUDY)
27. POOR RECOVERY FOLLOWING A SIGNIFICANT ANKLE SPRAIN: RISK FACTORS FROM A LARGE MULTICENTRE COHORT STUDY (SALI STUDY)
28. The Second Catalog of Interplanetary Network Localizations of Konus Short-duration Gamma-Ray Bursts
29. Data report: the Late Quaternary fossil record of holoplanktonic gastropods at IODP Sites U1395 and U1394
30. Casting off the Old Man: History and St. Paul in Henry IV (1970)
31. 933P Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study
32. Developing an indicator of productive potential to assess land use suitability in New Zealand
33. 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
34. Swift/UVOT follow-up of gravitational wave alerts in the O3 era
35. Frame Field Operators
36. Kinetics of the formation and destruction of PCDD/Fs in a laboratory tubular furnace
37. Recruitment pathways in the UK early detection initiative (UK-EDI) for pancreatic cancer study
38. GATA4 and GATA6 cooperate to drive tumor biology and patient outcome in human PDAC
39. The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer
40. SO-3 Treatment sequences and prognostic factors in metastatic pancreatic ductal adenocarcinoma: Univariate and multivariate analyses of a real-world study in Europe
41. P-229 Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma
42. OP0304-PARE DEVELOPMENT OF INTERACTIVE DECISION AID TOOL FOR MOTHERHOOD AND PARENTHOOD AMONG PATIENTS LIVING WITH AUTOIMMUNE RHEUMATIC DISEASES
43. Abstract No. 117 A phase 3, double-blind, randomized study of nivolumab and Ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma
44. Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’
45. The Unique Efficacy Profile of a β-Arrestin Pathway-Selective Parathyroid Hormone Receptor Agonist Revealed by Metabolic Pathways Analysis.
46. Two-dimensional infrared spectroscopy of Glycine-L-Alanine-Methylamide
47. Swift Multiwavelength Follow-up of LVC S200224ca and the Implications for Binary Black Hole Mergers
48. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
49. A bright γ-ray flare interpreted as a giant magnetar flare in NGC 253
50. Gemini Planet Imager Spectroscopy of the Dusty Substellar Companion HD 206893 B
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.